These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Feb. 13 through Feb. 19, 2025. Source: VerityData

Increases in Holdings

Zymeworks$(ZYME)$ EcoR1 Capital raised its stake in the oncology-focused biopharmaceutical company to 15,720,161 shares. EcoR1 Capital purchased 309,083 Zymeworks shares from Jan. 13 through Jan. 17, 2025, at per share prices ranging from $13.39 to $14.01.

Following the latest purchases, EcoR1 Capital continues to own 22.8% of Zymeworks' outstanding stock. Shares of Zymeworks have remained mostly flat since the beginning of this year.

Adecoagro$(AGRO)$ Tether Holdings raised its stake in the agricultural company to 20,398,699 shares. Tether Holdings purchased 350,450 Adecoagro shares from Jan. 3 through Jan. 17, 2025, at prices ranging from $9.56 to $10.01 each. Tether Holdings revealed an initial stake of 10,048,249 Adecoagro shares that it bought from July 29 through Aug. 16, 2024, at prices ranging from $9.45 to $11.66, and has been increasing its stake ever since. On Feb. 14, Tether Holdings made an offer to purchase 51% of Adecoagro's outstanding stock above market value for $12.41 per share in cash.

Following the stock purchases, Tether Holdings owns 20.2% of Adecoagro's outstanding shares. Shares of Adecoagro have gained roughly 12% since the beginning of this year and 9.7% since the offer was announced.

Decreases in Holdings

Pitney Bowes$(PBI)$ Hestia Capital Partners lowered its stake in the business services company to 14,186,244 shares. Hestia Capital Partners did so through the sale of 1,604,678 Pitney Bowes shares from Feb. 12 through Feb. 14, 2025, at per share prices ranging from $9.01 to $10.80.

Following the latest sales, Hestia Capital Partners continues to own 7.8% of Pitney Bowes' outstanding stock. Shares of Pitney Bowes have gained roughly 48.9% since the beginning of this year.

GeneDx Holdings(WGS) Icahn School of Medicine at Mount Sinai, or ISMMS, lowered its stake in the health-intelligence company to 1,680,016 shares. ISMMS did so through the sale of 1,039,676 GeneDx Holdings shares from Jan. 30 through Feb. 18, 2025, at per share prices ranging from $76.93 to $100.41.

Following the latest sales, ISMMS continues to hold a 6.1% stake in GeneDx Holding's outstanding stock. Shares of GeneDx Holdings have gained nearly 40% in value since the beginning of this year.

Nathan's Famous$(NATH)$ Gamco Investors reduced its stake in the fast-food franchiser and licenser to 521,247 shares. Gamco Investors did so through the sale of 13,400 Nathan's Famous shares from Dec. 16, 2024, through Feb. 13, 2025, at per share prices ranging from $78.20 to $95.57.

Following the latest sales, Gamco Investors continues to own 12.8% of Nathan's Famous' outstanding stock. Shares of Nathan's Famous have gained over a quarter in value since the beginning of 2025.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

February 21, 2025 16:31 ET (21:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.